Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 85
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 40
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

703 Results (Page 16 of 36)
- Relevance
  Sort by

Unresectable Hepatocellular Carcinoma Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Melanoma Drug Market by Distribution Channel, Route Of Administration, Line Of Therapy, Therapy Type, Mechanism Of Action - Global Forecast to 2030

 Report
May 2025
190 Pages
Global

From

€3115EUR$3,545USD£2,687GBP

€3461EUR$3,939USD£2,986GBP

Fallopian Tube Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
289 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
67 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immuno-Oncology - Thematic Intelligence

 Report
May 2023
169 Pages
Global

From

€7025EUR$7,995USD£6,060GBP

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

 Report
August 2018
340 Pages
Global

From

€3074EUR$3,499USD£2,652GBP

State of the Biopharmaceutical Industry 2023

 Report
December 2022
110 Pages
Global

From

€1713EUR$1,950USD£1,478GBP

Cardiovascular Collaboration and Licensing Deals 2016-2025

 Report
April 2025
300 Pages
Global

From

€3510EUR$3,995USD£3,028GBP

ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody Origin, Antibody Isotype, Type of Payload, Type of Linker and Key Geographical Regions

 Report
November 2024
510 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
121 Pages
Middle East

From

€1757EUR$2,000USD£1,516GBP

Metastatic Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2636EUR$3,000USD£2,274GBP

Retinopathy of Prematurity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
67 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

United States Ovarian Cancer Therapeutics Market, Competition, Forecast & Opportunities, 2028

 Report
October 2023
72 Pages
United States

From

€2614EUR$2,975USD£2,255GBP

€3075EUR$3,500USD£2,653GBP

Prostate Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Rheumatoid Arthritis Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2022
96 Pages
Global

From

€3500EUR$4,267USD£3,125GBP

Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
347 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3514EUR$3,999USD£3,031GBP

LAMEA Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Middle East, Africa

From

€1318EUR$1,500USD£1,137GBP

Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
82 Pages
Europe

From

€1318EUR$1,500USD£1,137GBP

703 Results (Page 16 of 36)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.